FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

100 letters match. Newest first.

  1. Pro-Optics, LLC

    FDA warned Pro-Optics about unapproved material and color changes to contact lens cases and quality system failures.

    Medium
  2. Tides Medical LLC

    FDA warns Tides Medical over APLICOR 3D wound device sold without approval, exemption, or required FDA notice.

    High risk
  3. O.N. Diagnostics, LLC

    FDA says O.N. Diagnostics sold changed VirtuOst VFA software without required clearance and had quality and reporting failures.

    High risk
  4. Advance-Esthetic LLC

    FDA says Advance-Esthetic markets three Zemits body-contouring devices without the required FDA clearance or approval.

    Medium
  5. Stephen J. Fallon, Ph.D.

    FDA warns clinical investigator Stephen J. Fallon, Ph.D. over consent and record failures in an HIV self-test study.

    High risk
  6. Nihon Kohden Digital Health Solutions, LLC

    FDA says Nihon Kohden Digital Health Solutions sold an uncleared monitor software change that can silence life-threatening alarms.

    High risk
  7. Skytron, LLC

    Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.

    High risk
  8. AseptiKits, LLC

    AseptiKits marketed unapproved sterile-preparation device kits without FDA clearance or approval, FDA says.

    High risk
  9. BMC Medical Co., Ltd.

    BMC Medical’s G3X APAP devices were misbranded/adulterated after significant changes without a new 510(k) and an unreported firmware fix.

    High risk
  10. Happiest Baby, Inc.

    FDA says Happiest Baby marketed unapproved SNOO sleep sacks and hospital bundle and mishandled complaints.

    High risk
  11. Estar Technologies Ltd

    FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.

    High risk
  12. Unetixs Vascular, Inc.

    Unetixs Vascular marketed modified ROODRA and 2CP vascular diagnostic devices without required FDA clearance.

    High risk
  13. 4U Health

    FDA says 4U Health sells an unapproved HIV dried blood spot self-collection kit, making it adulterated and misbranded.

    High risk
  14. Diasol, Inc.

    Diasol sold unapproved citric acid hemodialysis disinfectants and had quality system violations, FDA says.

    High risk
  15. ExThera Medical Corporation

    ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.

    High risk
  16. ProDx Health

    FDA warns ProDx Health that its HIV sample self-collection kits are sold without marketing authorization.

    High risk
  17. Germaphobix

    FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.

    High risk
  18. Genetrace

    FDA warned Genetrace that its HIV dried blood spot self-collection kit is unapproved and misbranded.

    High risk
  19. Genovate

    FDA warns Genovate over selling an unapproved HIV dried-blood-spot self-collection kit without marketing authorization.

    High risk
  20. LifeVac, LLC

    FDA warns LifeVac it is selling its Rescue Suction Device without required FDA approval.

    High risk
  21. SeniorLife Technologies, Inc.

    FDA warns SeniorLife Technologies that its SeniorLife.AI app is unapproved and misbranded, with quality-system and reporting failures.

    High risk
  22. Uscom Kft

    Uscom Kft marketed SpiroSonic AIR spirometer in the U.S. without FDA clearance and had multiple quality system failures at its Budapest plant.

    High risk
  23. O3UV, LLC

    FDA warns O3UV that its Champion and EBOO ozone/UV blood devices are unapproved, misbranded, and made without required quality controls.

    High risk
  24. WHOOP, Inc.

    FDA warns WHOOP it markets Blood Pressure Insights without device clearance or approval.

    High risk
  25. DRG Instruments GmbH

    FDA warns DRG Instruments over unapproved salivary cortisol ELISA devices and quality system and reporting violations.

    High risk
  26. United Health Products, Inc.

    FDA warns United Health Products over unapproved significant-risk study of CelluSTAT absorbable hemostat and trial oversight failures.

    High risk
  27. ICU Medical

    ICU Medical warned for changed Medfusion 4000 and CADD Solis infusion pumps sold without required FDA clearances.

    High risk
  28. Next Science LLC

    FDA warns Next Science that wound gels and irrigation solutions are adulterated and misbranded for uncleared claims and quality failures.

    High risk
  29. Rex Implants Inc.

    Rex Implants warned for unapproved dental implant devices and uncleared changes to its cleared implant system.

    High risk
  30. Exer Labs, Inc.

    Exer Labs marketed its Exer Scan device for AI diagnosis and treatment without FDA approval or clearance and lacked quality procedures.

    High risk
  31. Red Oak Instruments, LLC

    Red Oak Instruments marketed RU-Fit dynamometer for concussion screening without FDA clearance and had MDR and quality system violations.

    High risk
  32. Q’Apel Medical, Inc.

    Q’Apel Medical marketed an uncleared modified HIPPO stroke aspiration device and had quality system violations, FDA says.

    High risk
  33. Anne’s Daye Ltd dba Tampon Innovations

    FDA says Anne’s Daye marketed CBD-coated tampons and vaginal screening kits without required device clearance or approval.

    High risk
  34. Blackfly Investments, LLC dba Molecular® Testing Labs

    Blackfly Investments dba Molecular Testing Labs sells an HIV dried blood spot self-collection kit without FDA marketing authorization.

    High risk
  35. Mid-Link Testing Company, Ltd

    FDA warns Mid-Link Testing over unreliable Good Laboratory Practice (GLP) safety data for medical device tests.

    High risk
  36. Sanitation & Environmental Technology Institute dba SDWH

    FDA found GLP violations in SDWH's nonclinical testing of medical devices, raising doubts about safety data.

    High risk
  37. Shenzhen Moyeah Intelligent Life Technology Co.

    Shenzhen Moyeah sold ozone and UV CPAP cleaner and sanitizer devices in the U.S. without FDA clearance or approval, FDA says.

    High risk
  38. LEEL Tech

    FDA warns LEEL Tech that its CLYN, LEEL, and SOLID CPAP cleaners/sanitizers are sold in the U.S. without required clearance or approval.

    Medium
  39. Adventure Innovations LLC

    FDA says Adventure Innovations sold Sani Bot D3, a CPAP cleaner, without device clearance or approval.

    Medium
  40. Natures Pillows, Inc. and Top Dog Direct, LLC

    FDA warns Natures Pillows and Top Dog Direct that Clean Zone CPAP Sanitizer is an unapproved, misbranded device.

    High risk
  41. Baylab USA, LLC

    Baylab USA sold unapproved Level 1 masks, KN95 respirators and unclear colors and kids' versions of its Level 3 mask, FDA says.

    High risk
  42. AG Essence, Inc.

    FDA warned AG Essence that its Banda-SiL silver wound gels are adulterated and misbranded because they are sold without required FDA marketing clearance.

    High risk
  43. Trexo Robotics Holdings Inc.

    FDA warns Trexo Robotics over unapproved robotic gait-training legs for children and design-control gaps at its Canadian plant.

    High risk
  44. Ostar Beauty Sci-Tech Co Ltd.

    FDA warned Ostar Beauty Sci-Tech, a Chinese maker of microneedling pens, LED masks and fat-freezing pads, for selling unapproved medical devices in the US.

    High risk
  45. Cardinal Health

    Cardinal Health marketed convenience kits with unapproved syringes and lacked supplier qualification for infusion-pump-compatible Monoject syringes.

    High risk
  46. Soulaire Corporation

    FDA says Soulaire marketed an ECP device for unapproved uses without clearance or approval.

    High risk
  47. Agena Bioscience, Inc.

    Agena Bioscience marketed its iPLEX HS Colon Panel with the MassARRAY4 System for clinical diagnosis without FDA clearance or approval.

    High risk
  48. ReNovo, Inc. DBA Provision Device Reprocessing Solutions

    ReNovo, a device reprocessor in Bend, Oregon, sold new device models without required FDA clearances and had quality system failures.

    High risk
  49. Jiangsu Shenli Medical Production Co., Ltd.

    FDA says Jiangsu Shenli marketed many piston syringes in the U.S. without required clearance or approval.

    High risk
  50. Sol-Millennium Medical, Inc.

    Sol-Millennium marketed modified syringes and needles without required FDA clearance and had quality-system and reporting violations.

    High risk